TCG Crossover Management, LLC
- SEC CIK
- 0001839948
- Latest filing
- Aug 14, 2026
DNTH holding history
Dianthus Therapeutics, Inc. in every 13F filed by TCG Crossover Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DNTH overviewAll 13F holders of DNTHFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,676,624
- Value
- $163.4M
- % of portfolio
- 3.9%
- Quarters held
- 11
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,676,624 | $163.4M | 3.9% | 00.0% | Unchanged | Holders |
| Q1 2026 | 1,676,624 | $140.7M | 4.0% | 00.0% | Unchanged | Holders |
| Q4 2025 | 1,676,624 | $69.1M | 2.3% | 00.0% | Unchanged | Holders |
| Q3 2025 | 1,676,624 | $66.0M | 3.2% | +175,000+11.7% | Added | Holders |
| Q2 2025 | 1,501,624 | $28.0M | 3.2% | 00.0% | Unchanged | Holders |
| Q1 2025 | 1,501,624 | $27.2M | 3.7% | 00.0% | Unchanged | Holders |
| Q4 2024 | 1,501,624 | $32.7M | 3.2% | +1,501,624 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −2,124,122−100.0% | Sold out | Holders |
| Q3 2022 | 2,124,122 | $3.00M | 0.9% | 00.0% | Unchanged | Holders |
| Q2 2022 | 2,124,122 | $2.55M | 1.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 2,124,122 | $6.16M | 2.5% | −98,100−4.4% | Reduced | Holders |
| Q4 2021 | 2,222,222 | $9.84M | 4.6% | – | No prior filing | Holders |